Financial
FY2026 revenue $74.18bn (+6.0%); operating margin 15.4%; net income $8.37bn.
Cash $12.83bn; debt $10.11bn.
Accenture
HQ Ireland · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Strong
Customer rating
No reviews yet
Financial health
Band: StrongListed: ACN
FY2026 revenue $74.18bn (+6.0%); operating margin 15.4%; net income $8.37bn.
Cash $12.83bn; debt $10.11bn.
Source: official results release · Year ended 2026-08-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2026 | US$74.2bn | +6.0% | US$11.4bn | US$8.4bn | Accenture |
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
Sep 2026: Accenture agreed to pay the US government $25m to settle False Claims Act allegations that it considered race and sex in hiring and promotion at its federal services arm; the DOJ said the claims are allegations only, with no finding of liability.
Cyber & information governance
Jul 2026: Accenture confirmed a security incident after a hacker claimed to be selling 35GB of its data, allegedly including source code and cloud access keys. Accenture said the matter was isolated and remediated, with no impact on operations. NHS DSPT status not yet checked.
Regulatory & clinical safety
IT services and consulting supplier; no regulatory or clinical safety actions found in the last 24 months.
Contract performance
No notable NHS contract awards, troubled implementations, terminations or customer disputes involving Accenture found in HSH's search of the last 24 months.
Competitors
No competitors linked yet.